Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Total Assets : ¥5,640 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Total Assets?

Hubei Hongyuan Pharmaceutical Technology Co's Total Assets for the quarter that ended in Mar. 2024 was ¥5,640 Mil.

Warning Sign:

If a company builds assets at 21.9% a year, faster than its revenue growth rate of 10.2% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Hubei Hongyuan Pharmaceutical Technology Co's average Total Assets Growth Rate was 4.30% per year. During the past 3 years, the average Total Assets Growth Rate was 36.10% per year. During the past 5 years, the average Total Assets Growth Rate was 21.90% per year.

During the past 10 years, Hubei Hongyuan Pharmaceutical Technology Co's highest 3-Year average Total Assets Growth Rate was 36.10%. The lowest was 11.70%. And the median was 26.50%.

Total Assets is connected with ROA %. Hubei Hongyuan Pharmaceutical Technology Co's annualized ROA % for the quarter that ended in Mar. 2024 was 2.21%. Total Assets is also linked to Revenue through Asset Turnover. Hubei Hongyuan Pharmaceutical Technology Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.08.

Hubei Hongyuan Pharmaceutical Technology Co Total Assets Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Total Assets Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

1,782.55

1,760.50

2,432.26

3,875.47

5,650.77

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
	Jun15	Dec15	Jun16	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															5,946.69	5,709.79	5,560.24	5,650.77	5,640.26

Hubei Hongyuan Pharmaceutical Technology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hubei Hongyuan Pharmaceutical Technology Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	4359.837	+	1290.933
	=	5,651

Hubei Hongyuan Pharmaceutical Technology Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	4392.51	+	1247.753
	=	5,640

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Total Assets Explanation

Total Assets is connected with ROA %.

Hubei Hongyuan Pharmaceutical Technology Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	124.796	/	( (5650.771	+	5640.263)	/ 2 )
	=	124.796	/	5645.517
	=	2.21 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hubei Hongyuan Pharmaceutical Technology Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	426.064	/	( (5650.771	+	5640.263)	/ 2 )
=	426.064	/	5645.517
=	0.08

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hubei Hongyuan Pharmaceutical Technology Co Total Assets Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600

Website

http://www.hbhypharm.com

Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines